Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease-Reference-Cited by-同舟云学术

Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease

Published:2016-06-27 Issue:10 Volume:22 Page:817-823
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Kang Young-Sook¹,Jung Hyun-Joo¹,Oh Ji-Suk¹,Song Dae-Yong²

Affiliation:

1. College of Pharmacy; Research Institute of Pharmaceutical Science (RIPS) and Research Center for Cell Fate Control; Sookmyung Women's University Chungpa-dong 2-ga; Seoul Korea

2. Department of Anatomy and Neuroscience; Eulji University School of Medicine; Daejeon Korea

Funder

National Research Foundation of Korea

Korean government (MSIP)

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cns.12580/fullpdf

Reference45 articles.

1. Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease;Lindner;Cell Transplant,1998

2. The genetic epidemiology of neurodegenerative disease;Bertram;J Clin Invest,2005

3. Parkinson's disease: mechanisms and models;Dauer;Neuron,2003

4. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys;Villalba;Exp Neurol,2009

5. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease;Deleu;Clin Pharmacokinet,2002

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29

2. To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges;Journal of Controlled Release;2024-07

3. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22

4. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier;International Journal of Nanomedicine;2024-03

5. Nanoencapsulation of general anaesthetics;Nanoscale Advances;2024